The ‘double whammy’ of low prevalence in clinical risk prediction

Registros relacionados

• Flurona a double whammy
  por: Vethasalam, Ragananthini
  Publicado em: (2022)
• ‘Double Whammy’?! Historical Glimpses of Black Deaf Americans
  por: Anja Werner
  Publicado em: (2018-02-01)
• Sickle cell and autoimmune disease: a double whammy
  por: Arne M. de Kreuk
  Publicado em: (2024-05-01)
• COVID-19 and tuberculosis: the double whammy of respiratory pathogens
  por: Mohd Shariq, et al.
  Publicado em: (2022-04-01)
• Evidence that an <it>APOE </it>ε4 'double whammy' increases risk for Alzheimer's disease
  por: Caesar Ina, et al.
  Publicado em: (2012-04-01)